Investing
I was happy to see last week the results of the Federal Reserve’s annual stress test of 23 of the nation’s largest banks. Each...
Hi, what are you looking for?
Repay Down
Investing
Cisco Systems Inc. gave some more details on the timing of revenue from its anticipated orders related to artificial intelligence, and it looks like...
Investing
Long-term investors have been well served by index funds, which often charge very low fees and can be hard for active portfolio managers to...
Investing
If you see a headline that a company beat analysts’ expectations when reporting its quarterly results, it may not mean very much. The analysts...
Investing
The U.S. economy added 209,000 jobs in June, a healthy number that surpassed some forecasts but fell short of the surge reported for May. Don’t...
Investing
Shares of Costco Wholesale Corp. COST, -1.22% dropped nearly 1% in the extended session Thursday after the retailer reported June sales of $22.86 billion,...
Investing
Nikola’s stock drops nearly 2% after EV maker fails to secure shareholder support for new-stock plan
Shares of Nikola Corp. NKLA, +11.42% fell almost 2% in the extended session Thursday after the EV maker said it adjourned its shareholder meeting...
Investing
Week In Review June’s Caixin PMI came in slightly better than anticipated at 50.5 versus an expected reading of 50 and May’s 50.9. BYD...
Investing
Well, you might have to connect the dots — er, threads — but there’s enough of a link that some legal experts say it...
Investing
Private-equity firm L Catterton is considering strategic options for iconic German sandal maker Birkenstock, including a potential initial public offering, Bloomberg reported Thursday, citing...
Investing
Mallinckrodt PLC MNK, -5.26% shares surged in the extended session Thursday after the Dublin-based drug maker and distributor said it was open to proposed...
Investing
Bitcoin was rising modestly Thursday, with the largest digital asset holding onto gains from a recent rally but in need of more catalysts to...
Investing
The U.S. Food and Drug Administration on Thursday granted full approval to the Biogen BIIB, -0.31% and Eisai Co. Ltd. ESALF, +1.20% Alzheimer’s treatment...
